CDKN2A and Miyoshi myopathy: Yet, high-level MET-GCNG/GA might occur at low frequency also in MM, as a genomic analysis of 13 peritoneal MMs showed one case harboring focal high-level amplification of the MET oncogene, in addition to a structural rearrangement involving BAP1 and homozygous deletion of CDKN2A [12].